Patients sue GLP-1 drugmakers over potential risk of sudden vision loss
The Wall Street Journal reports that warning labels outside the U.S. note sudden vision loss as a potential risk of the popular diabetes and weight-loss drugs.
TLDR
Patients are suing makers of GLP-1 diabetes and weight-loss drugs over the potential risk of sudden vision loss, The Wall Street Journal reports. The Journal describes the potential risk as little-discussed and says it appears on warning labels outside the U.S.
Patients sue GLP-1 drugmakers over potential risk of sudden vision loss
The Wall Street Journal reports that warning labels outside the U.S. note sudden vision loss as a potential risk of the popular diabetes and weight-loss drugs.
TLDR
Patients are suing makers of GLP-1 diabetes and weight-loss drugs over the potential risk of sudden vision loss, The Wall Street Journal reports. The Journal describes the potential risk as little-discussed and says it appears on warning labels outside the U.S.